Page 24 - Access Pool News Today

AstraZeneca has claimed it does not have enough engineers to help share its vital Covid vaccine technology with other global manufacturers, as other pharmaceutical giants face growing pressure to relinquish their control over the production of the life-saving jabs. Amid a global shortage of supplies, health campaigners have called on the likes of AstraZeneca, Pfizer, Moderna and others to waive their intellectual property (IP) rights and...

Commentary: Glaring vaccine gaps across the world are too big to ignore Toggle share menu Advertisement Commentary: Glaring vaccine gaps across the world are too big to ignore Many hoped the pandemic would end proprietary science and patent-based market monopolies. That hope has since faded, says Kaushik Basu. FILE PHOTO: A health worker prepares a dose of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at the Tecn...

May 3, 2021 ITHACA, New York – As the second wave of the COVID-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as Bangladesh, Pakistan, Turkey, the Philippines, Ethiopia, and Kenya. There are many reasons for this divide, but uneven access to hea...

Inequity in access to Covid-19 vaccines abets second wave Kaushik Basu More than one billion vaccine doses have now been administered worldwide, but vast disparities remain. As the second wave of the Covid-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as ...

Vaccine companies and the U.S. government snubbed WHO initiative to scale up global manufacturing Emily Baumgaertner © (Rafiq Maqbool / Associated Press) The Serum Institute in India has been responsible for manufacturing vaccines for much of the world. (Rafiq Maqbool / Associated Press) COVID-19 vaccines were still in the early stages of development last spring, but Costa Rican President Carlos Alvarado Quesada was thinking ahead. Even if those efforts were successful, he fi...

Print COVID-19 vaccines were still in the early stages of development last spring, but Costa Rican President Carlos Alvarado Quesada was thinking ahead. Even if those efforts were successful, he figured, wealthy nations alone wouldn’t be able to make enough vaccine to quickly inoculate billions of people. His solution: a program, launched by the World Health Organization last May that aimed to train dozens of pharmaceutical manufacturers in Latin America, Asia and Africa to increase worldwid...

Developing countries are dealing with a shortage of coronavirus vaccines, with the hoarding of supply and the protection of intellectual property in affluent nations two reasons why.

US Senators ask vaccine companies to share supply plans for India, world SECTIONS Share Synopsis They have suggested that the companies share their vaccine technology and manufacturing information with other companies to speed up production. AP If this proposal goes through, it would temporarily lift certain intellectual property barriers and allow countries to locally manufacture Covid-19 diagnostics, treatments, and vaccines, the senators said. Five US senators led by Elizabeth Warren have w...

An amendment calling on the EU to back India and South Africa’s proposal to temporary lift intellectual property rights for the COVID-19 vaccine was rejected by the European Parliament on Thursday (29 April). The question of suspending IP rights for COVID-19 treatments and vaccines was first tabled by India and South Africa in a proposal to the World Trade Organization (WTO) which was backed by around 100 other countries. According to the proponents, an IP waiver for vaccine patents could s...

More than 60 people protested outside Moderna’s headquarters in Cambridge on Wednesday to demand expanded global access to COVID-19 vaccines as the virus runs rampant in India, and Massachusetts’ two US senators expressed support for expanded international availability.